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1.1 The cAMP-dependent signal transduction pathway 
Living cells are exposed to multiple stimuli and the tight regulation 
of the transduction pathways activated by these signals is crucial 
to elicit phyisiological responses. Extracellular messengers, such as 
hormones, neurotransmitters and growth factors, regulate 
different cellular processes, as cellular differentiation and division, 
ionic channels activity, gene transcripton and protein translation.  
The binding of these molecules to specific cellular receptors elicits 
cellular responses. Plasma membrane receptors transmit the 
signals of the specific hydrophilic messengers, generating 
biophysical modification or increasing intracellular signalling 
molecules concentration known as second messengers. 
The first second messenger identified is the cyclic AMP (cAMP) 
(Sutherland et al., 1970). cAMP-dependent transduction pathway 
is mediated by G-coupled receptors that activate the adenylyl 
cyclase (AC), ubiquitous enzyme converting ATP  in cAMP. In 
mammals, the ubiquitous second messenger cAMP is synthesized 
by two classes of AC: the G protein responsive transmembrane 
adenylyl cyclases (tmACs) and the widely distributed, bicarbonate-
responsive, soluble adenylyl cyclase (sAC) (Chen et al., 2000). 
tmACs are characterized by a short NH2-terminal amino-acidic 
segment and by two cytoplasmic domains (C1 and C2) separated 
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by two highly hydrophobic transmembrane domains (M1 and M2).  
C1 and C2 constitute catalytic site of adenylyl cyclase.  
cAMP mediates its cellular effects via at least three distinct classes 
of direct effectors; cAMP-dependent protein kinase (PKA), RAP 
exchange proteins (EPACs), and cAMP gated ion channels (cNGC). 
cNGCs and a subset of PKA targets are localized to the plasma 
membrane, near tmACs, in what appear to be macromolecular 
signaling complexes comprising the G protein coupled receptor, G 
protein, tmAC, and PKA and its ultimate substrate (Zippin et al., 
2002) (Fig. 1) 
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Figure 1. Schematic diagram of cAMP synthesis and downstream 
effector activation. When an extracellular ligand such as an hormone 
binds to and activates a seven-transmembrane G-protein-coupled 
receptor, the signal is passed through the heterotrimeric G protein to 
adenylyl cyclase. The activated adenylyl cyclase converts ATP into the 
second messenger cAMP. As the gradient of cAMP concentration 
diffuses in the cell, various enzymes or effectors are activated. 
These include PKA, PDE and EPAC. The interplay of each of these 
effectors as they interact directly or indirectly with each other and other 
downstream targets is currently an area of intense study. 
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1.2 Protein Kinase A (PKA)  
Activation of PKA is solely accomplished by the major, diffusible 
secondary messenger cAMP (Su et al., 1995).  PKA Holoenzyme is a 
serine/threonine kinase constitutes by two catalytic subunits 
(PKAc or C) that are helded in an inactive complex by a dimer of 
regulatory subunits (Rs). Binding of cAMP to each R subunit 
relieves the autoinhibitory contact, allowing the C subunits to 
dissociate (Wang et al., 1991) thereby resulting in phosphorylation 
of local substrates (fig. 2). PKA-dependent phosphorylation of 
nuclear and cytoplasmic substrates controls multiple cell 
functions, including motility, metabolism, differentiation, synaptic 
transmission, ion channel activities, growth and coordinate gene 
transcription (Edelman et al., 1987; Taylor et al., 1992; Meinkoth 
et al., 1993; Montminy et al., 1997). 
Two forms of the heterotetrameric PKA holoenzyme exist: type I 
(RI and RI dimer) and type II (RII and RII dimer). Type I PKA is 
predominantly cytoplasmic, whereas type II PKA associates with 
specific cellular structures and organelles. Catalytic subunits are 
encoded from three different genes Cα, Cβ e Cγ, that show 
common kinetic features and substrate specificity (Taylor et al., 
1992). Four genes encode the R subunits R1α, R1β, R2α e R2β 
(Taylor et al., 1992), that confer the different biochemical and 
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biological characteristics to the PKA isoforms. The R subunit is a 
modular polypeptide containing an NH2-terminal dimerization 
domain, an autophosphorylation site that serves as a principal 
contact site for the C subunit, and two cAMP binding sites.  
The R subunits are differentially distributed in mammalian tissues. 
RI and RII are ubiquitous, whereas RII is expressed 
predominantly in endocrine, brain, fat and reproductive tissues 
(Edelman et al., 1987; Taylor et al., 1992). In addition to their 
distinctive expression and distribution, R subunits differ in their 
regulation and biochemical properties. The binding affinity to 
cAMP of RII in vivo is lower relative to RII and much lower 
compared to RI (Edelman et al., 1987; Taylor et al., 1992).  
These data imply that holoenzymes containing RI subunits or RII 
subunits (PKAI and PKAII) decode cAMP signals that differ in 
duration and intensity: PKAI is activated transiently by weak cAMP 
signals, whereas PKAII responds to high and persistent cAMP 
stimulation. Neurons and endocrine cells, which express 
predominantly PKAII, are adapted to persistent high 
concentrations of cAMP (Stein et al., 1987).  The specific 
biochemical properties of PKA isozymes account, in part, for the 
differential cellular responses to discrete extracellular signals that 
activate adenylyl cyclase. 
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The function(s) in vivo of the specific PKA isoforms in gene 
expression and cell signaling has been probed using knockout (KO) 
and transgenic mouse models (Brandon et al., 1995a). Ablation of 
the gene encoding the RI tether to deficits in hippocampal long-
term depression and depotentiation (Qi et al., 1996; Brandon et 
al., 1995b). Despite a compensatory increase in total PKA activity, 
in the RI KO mice, hippocampal function is impaired, suggesting a 
unique role for RI in synaptic plasticity (Amieux et al., 1997). A 
targeted disruption of the RII gene yields viable mice with no 
physiological abnormalities, implying that PKAI and/or PKAII 
compensates for the RII defect (Burton et al., 1997, 1999). 
Targeted disruption of the mouse RII gene has additional 
physiological consequences. The mutant mice are lean and have 
elevated metabolic rates caused by increases in both basal PKA 
activity and the basal rate of lipolysis (Cummings et al., 1996; 
McKnight et al., 1998). RII KO mice also display defects in 
neuronal gene expression, learning and behaviour (Adams et al., 
1997; Brandon et al., 1998).  
Living cells developed several regulation system to control the 
effects of the cAMP/PKA signaling pathway.  Termination of cyclic-
nucleotide signaling is achieved by PDEs, a superfamily of > 70 
different isozymes that degrade cAMP and cyclic GMP (cGMP). 
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Distinctive tissue distribution, subcellular compartmentalization 
and differential regulation of these enzymes contribute to the 
establishment of local cAMP gradients by limiting the diffusion of 
cAMP that is generated by adenylyl cyclases (Houslay et al., 2003). 
The type-4 PDEs are a family of  > 16 distinct isoforms that have a 
conserved catalytic core. Divergence within the N-terminal region 
of PDE4 isoforms enables association with various proteins and, 
therefore, differential subcellular targeting and regulation. 
Importantly, the PDE4D3 isozyme has been shown to be part of 
signaling complexes that target PKA.  
The action of PKA, as with many other serine/threonine kinases, is 
counterbalanced by specific protein phosphatases. In some cases, 
it has been demonstrated that phosphatases belonging to the PP1 
and PP2A families are responsible for dephosphorylation of PKA 
substrates. In turn, PKA can control phosphatase activity by 
phosphorylation of specific PP1 inhibitors, such as I-1 and 
DARPP32 (Fimia et al., 2000). 
PKA is targeted at specific intracellular microdomains through 
interactions with A-Kinase-Anchor-Proteins (AKAPs). AKAP forms a 
local transduction unit, which includes different 
signalling/metabolic enzymes, receptors, ion channels, adaptor 
molecules and mRNAs. In this context, the spatio-temporal kinase 
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activation provides a control mechanism to direct, integrate and 
locally attenuate the cAMP cascade. 
 
 
 
Figure 2. PKA molecular structure and activation mechanism. 
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1.3  AKAP proteins 
Subcellular targeting through association with anchoring proteins 
has emerged as an important mechanism by which the cells 
localize signalling enzymes to sites where they can be accessed 
optimally by activators and, in turn, interact with particular 
substrates. The PKA is  concentrated in particulate membranes 
and cellular organelles through interaction with a family of non-
enzymatic scaffold proteins: A Kinase Anchor Proteins (AKAPs) 
(Rubin, 1994; Edwards & Scott, 2000; Dodge & Scott, 2000).  
AKAPs are a group (> 50 proteins) functionally, rather then 
structurally, related proteins and each contains  a common RII-
binding site  formed by 14–18 amino acid amphipathic aligned  
along one face of the helix and charged residues and the other 
side, that bind amino termini of PKA-RII dimer (Carr et al., 1991; 
Newlon et al., 1999) (Fig. 3). The first 30 amino acid residues of RII 
participate in AKAP binding, as shown by site-directed 
mutagenesis, biochemical analysis and solid-phase binding assays 
(Li & Rubin, 1995; Hausken et al., 1994, 1996). These residues also 
promote dimerization of RII subunits, which is a prerequisite for 
binding to AKAP. Although most AKAPs that have been 
characterized to bind to RII subunits with high affinity, several 
AKAPs have been reported to interact specifically with RI. 
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RII subunits bind to AKAPs with nanomolar affinity, by contrast, RI 
subunits bind to AKAPs with only micromolar affinity. However D-
AKAP1 and D-AKAP2 are examples of dual-specificity AKAPs that 
can anchor both types of R subunit (Huang et al., 1997; Wang et 
al., 2001). 
Structural data indicate that there is a single region of multiple 
contact sites between the RII subunit dimer and the AKAP, which 
presumably for the high-affinity interaction. Functionally, this 
suggests that the AKAP–PKA complex is likely to be a constitutive 
interaction in cells and not subject to regulation. However, the 
distribution of the PKA holoenzyme can be altered upon induction 
of AKAP expression. Thereby, regulation of PKA localization might 
be a function of AKAP targeting. 
Each AKAP also contains a subcellular targeting domain that 
restricts its localization within the cell. A combination of 
subcellular-fractionation and immunohistochemical studies have 
identified AKAPs in association with a variety of cellular 
compartments, including centrosomes, dendrites, endoplasmic 
reticulum, mitochondria, nuclear membrane, plasma membrane 
and vesicles. Although AKAPs have been defined on the basis of 
their interaction with PKA, an additional feature of many of these 
molecules is their ability to bind to other signalling enzymes, such 
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as protein phosphatases and kinases. AKAPs form a multiproteic 
complex with the presence of signal transduction and signal 
termination enzymes in the same network. This creates focal 
points of enzyme activity where the bidirectional regulation of 
signaling events can be controlled and the phosphorylation status 
of target substrates is precisely regulated. (Feliciello et al., 2001) 
AKAP forms a ``transduceosome'' by acting as an autonomous 
multivalent scaffold that assembles and integrates signals derived 
from multiple pathways. The transduceosome amplifies cAMP and 
other signals locally and, by stabilizing and reducing the basal 
activity of PKA, it also exerts long-distance effects. The AKAP 
transduceosome thus optimizes the amplitude and the 
signal/noise ratio of cAMP-PKA stimuli travelling from the 
membrane to the nucleus and other subcellular compartments 
(Feliciello et al., 2001). 
Importantly, Besides kinase and phosphatase, recent reports have 
demonstrated that phosphodiesterases, the enzymes that catalyze 
cAMP metabolism, are present in complex with AKAP and PKA. 
These findings add a novel twist to PKA regulation, as they indicate 
that an anchored pool of phosphodiesterase may tightly control 
local cAMP levels.  
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AKAPs, anchoring the PKA in close proximity of the substrates, 
optimize the PKA-dependent phosphorylation of a plethora of 
cellular substrates.  
Cells that express high levels of membrane-bound PKA are more 
sensitive the cAMP increase  (Feliciello et al., 1998, Feliciello et al., 
2000). This might be explained by the fact that membrane-bound 
PKA is more stable than the cytosolic enzyme (Feliciello et al., 
1996). PKA levels are higher in cells containing a high fraction of 
membrane-bound PKA, and the effects of PKA activation are more 
readily transmitted from the point of cAMP generation at the cell 
membrane (Lester et al., 1997; Paolillo et al., 1999; Cassano et al. 
1999). 
This interaction between AKAPs and cAMP, defines a positive 
regulatory loop in which the second messenger stimulates AKAP 
expression that in turn enhances cAMP dependent signaling 
pathway. In this way anchor proteins are involved in a potent 
regulatory mechanism that, coordinating and integrating several 
cellular processes, controls the specificity of signal transduction.  
In higher eukaryotes, essential functions such as neurite 
outgrowth and morphogenesis, synaptic transmission, hormones 
production and release, require tightly regulated response to PKA 
stimulation. 
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The cAMP/PKA pathway plays a crucial role in synaptic plasticity in 
a wide variety of species. Pharmacological or genetic inhibition of 
PKA severely affects the induction of hippocampal long-term 
potentiation (LTP) and inhibits synaptic plasticity and long-lasting 
memory (Huang et al., 1994). In Aplysia sensory neurons, the 
switch from short-term (STF) to long-term facilitation (LTF) is 
essential for initiating stable long-term memory. Ubiquitin-
dependent proteolysis of R subunits sustains nuclear PKAc 
signaling and promotes transition from STF to LTF, thereby 
contributing to synaptic strengthening (Chain et al., 1999a, 1995 
1999b; Hedge et al., 1997). In mammals, proteolysis of R subunits 
has been linked mechanistically to differentiation and co-
ordinated progression through cell cycle (Feliciello et al., 2000). 
However, the identity of the E3 ubiquitn ligase controlling PKA 
stability in eukaryotes is so far unknown. 
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Figure 3. Consensus sequence of AKAP-RII-binding domains.   
Consensus sequence derived from the alignment of the primary 
sequences of several AKAPs (upper). The amphipathic helical wheel and 
the residues forming it are depicted as a thick line (lower). 
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1.4  praja2 
Regulation of protein stability is largely mediated by ubiquitin 
ligases, which mark their substrates for efficient proteasome-
dependent degradation (Hershko et al., 1998). The conjugation of 
ubiquitin moieties to substrates requires coordinated action of the 
ubiquitin activating enzyme (E1), the ubiquitin conjugating enzyme 
E2 and the E3 ligase, which associates with the substrate and 
thereby determines the specificity in degradation of various 
substrates (Ciechanover, 1998) (Fig. 4). 
The RING finger ubiquitin E3 ligases contain a characteristic 
cysteine-rich zinc binding domain defined by a pattern of 
conserved cysteine and histidine residues. These ligases efficiently 
catalyze poly-ubiquitination of given substrates (Joazeiro et al., 
2000). Characteristic of RING finger ubiquitin E3 ligases is the 
ability to mediate degradation of their substrates, as well as their 
own availability, by promoting their own ubiquitination-
dependent degradation (Lorick et al., 1999). 
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Figure 4.  Schematic representation of proteasomal degradation. 
 
praja2 (PJA2) could be categorized into Ring H2 finger E3 ubiquitin 
ligase subfamily. Structural studies and sequence analysis, in fact, 
revealed that this protein  contains at COOH-terminal end (aa 629-
678) a characteristic sequence domain known as the RING-H2-
finger motif (Freemont, 1993). [the RING-H2-finger motif is closely 
related to the RING-finger motif, and Cys4 in the RING-finger motif 
is replaced by His (Freemont, 1993)] (Fig. 5). 
praja E3 ligase family recognises two members that share high 
sequence homology. 
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Figure 5. Sequence alignment of the RING-H2-finger family.  
The metal binding ligands, which are absolutely conserved between the 
family members, are indicated by asterisks, as are the positions of 
conserved hydrophobic residues indicated by #. The numbering (1-6 and 
1-2) below each conserved Cys and His refers to the potential metal 
binding ligands C1-C6 and H1-H2, respectively. The numbering in 
parentheses refers to the protein sequence. 
 
 
praja2 gene is localized on the long arm of human chromosome 5 
(5q21). 5.2 Kbp transcript encodes a 708 amino-acidic residues 
protein, with an estimate weight of 78 Kda (Nakayama et al., 
1995). 
praja1 (PJA1) gene mapped on human chromosome X. Northern 
blot analysis identify a 2.7 Kbp ribonucleotide transcript, coding a 
643 amino-acids protein, with an estimate  weight of 71 kda (Ping 
et al., 2002).  
Furthermore, different splice variants have been recognized. 
praja1 shows high sequence homology with praja2 (52.3% of 
identity). Besides the COOH terminal domain contains an highly 
conserved RING H2 Finger domain. (Fig. 6). 
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Figure 6. Human praja2 and its orthologous and homologous proteins 
in different species. 
 (A) Multiple sequence alignment of RING-H2 regions from praja2 and 
praja1 sequences across various species. Loops and predicted 
coordination sites are indicated above. Similar amino acids are in gray 
and different amino acids are in black boxes. The RING-H2 consensus 
sequence is CX2CX(9–39)CX(1–3)HX(2–3)HX2CX(4–48)CX2C. (B) A 
phylogenetic tree of praja1 and homologous sequences generated from 
sequence alignments. The scale bar beneath the tree represents 10 
substitutions per 100 residues. (C) Representation of praja1 and praja2 
proteins with RING-H2 motifs. Dashed lines represent incomplete 
sequences. A dashed open box represents an incomplete sequence of 
RING-H2 motif. The percent identity/similarity for each of these eight 
proteins compared with the human praja1 is shown on the right side. 
The names of each of these proteins are respectively listed in (B). 
 
Interestingly praja1 expression is pronounced and show learning-
specific induction in the basolateral complex of the amygdala 
during formation of fear memory (Stork et al., 2001). These 
findings support an important role in mice for praja1 in neuronal 
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plasticity that is the basis for learning and memory (Ping et al., 
2002). 
Moreover  praja1 gene mapped into human chromosome Xq12, 
where several X-linked mental retardation (MRX) disorders have 
been associated (Wilson et al., 1991; Siderius et al., 1999). 
Neurodap1 (Ndap1, Neurodegeneration associated protein 1) 
gene, the praja2 rat ortolog, is localized on the chromosome 9 
(9q37). 4.8 Kbp ribonucleotide transcript encodes a 707 amino-
acidic residues RING H2 Finger protein (with an estimate weight of 
78 Kda), that shows the 88%  identity with praja2.  
Although the molecular mass of Ndap1 and praja2 is estimated to 
be about 140 kDa by SDS-polyacrylamide electrophoresis, this 
value is larger than the expected one deduced from the primary 
structure (about 80 kDa).  This discrepancy between the expected 
and observed molecular masses might be explained by anomaly of 
protein migration rates on SDS-polyacrylamide gel (Ohara and 
Teraoka, 1987). 
RNA blotting analysis in rat revealed that the brain is the most 
abundant in Ndap1 mRNA among different tissues. Lower 
expression levels were found into the spleen, lung, liver, kidney, 
testis, heart, thyroid and skeletal muscle (Nakayama et al., 1995). 
 25 
 
By in situ hybridization the signals for mRNA of Ndap1 were 
observed exclusively on the perikaryal cytoplasm of neuronal cells, 
especially on that of large-sized nerve cells, such as pyramidal cells 
in the cerebral cortex or hippocampus, Purkinje cells and those in 
the brainstem (Nakayama et al., 1995). 
Strong hybridization signals for mRNA of Ndap1 were observed on 
the large nerve cells of the facial nuclei, instead weaker signals 
were detected on the granule cells of the hippocampal dentate 
gyrus.  
Immunoistochemistry analysis on 1 M thick sections revealed 
that Ndap1 was distributed in the cytoplasm forming a 
characteristic punctate pattern and that the distribution of the 
protein in the brain cells was identical to  that of the mRNA-
positive cells observed by in situ hybridization (Nakayama et al., 
1995).  Immunoelectron microscopy analysis shows that  Ndap1 is 
expecially  concentrated around the cytoplasmic surface of 
endoplasmic reticulum (ER), Golgi apparatus, some tiny vesicles 
and cell membrane. 
In particular, the immunoreactivity of Ndap1 was often observed 
in the postsynaptic density (PSD) region of axosomatic synapses: 
35% of the PSDs of axosomatic synapses is decorated with Ndap1 
in the nerve cells of the facial nucleus, whereas most of the PSDs 
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of axosomatic synapses in the cerebral cortex are associated with 
Ndap1. This observation indicates that the association of Ndap1 to 
PSD significantly depends on types of PSD (Nakayama et al., 
1995). 
Following axotomy, axonal degeneration and neuronal cell death 
correlate with strong down-regulation of Ndap1 expression levels 
(Nakayama et al., 1995).  Thus, regulating synaptic communication 
and plasticity,  PSDs formation and  nerve cells viability, praja 
family proteins may play a crucial role in neuronal activity and 
development (Nakayama et al., 1995).     
Ubiquitin-dependent protein degradation is involved in many 
cellular processes regulation, such as cell cycle progression and 
signal transduction, transcription and DNA repair, apoptosis and 
vescicular transport. 
Interestingly, several RING finger genes have been found that are 
mutated in human diseases (Mattson et al., 2001; Kitada et al., 
1998). For instance, the parkin gene was found to be mutated in 
autosomal recessive familial juvenile Parkinsonism (Kitada et al., 
1998). Many RING finger proteins have unknow functions or 
unrelated to the ubiquitination in evident manner. 
Structural data and sequence analysis identified in praja2 COOH 
terminal domain (aa 583-600) a particular motif, highly conserved 
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among all the praja family members, encoding an  amphipathic 
helix. This domain is characteristic of AKAPs family proteins, and is 
known to be foundamental for PKA anchoring (Fig. 3). 
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AIM OF THE STUDY 
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The relative abundance of R and PKAc subunits contributes to the 
strength and duration of cAMP signalling. Increased PKAc activity 
sustains downstream cAMP signalling impacting on different 
aspects of cellular behaviour (Davis et al., 1998; Amieux et al., 
2002). Several studies reaveal that ubiquitin-dependent 
proteolysis of R subunits, sustaining nuclear PKAc signaling, 
promotes transition from STF to LTF, thereby contributing to 
synaptic strengthening and memory formation (Chain et al., 
1999a, 1995 1999b; Hedge et al., 1997). In mammals, proteolysis 
of R subunits has been linked mechanistically to differentiation 
and co-ordinated progression through cell cycle (Feliciello et al., 
2000). However, the identity of the E3 ubiquitn ligase controlling 
PKA stability in eukaryotes is so far unknown. 
Using a yeast two hybrid screening, we found praja2 as novel 
interactor of PKA regulatory subunits.   
praja2 is a member of RING H2 Finger E3 ubiquitin ligase. 
Furthermore computational analysis revealed an amphipathic 
−helix (prototypical AKAPs R-binding domain) in COOH terminal 
of the protein. 
These data prompted us to investigate if E3 ligase praja2 may 
anchor PKA and regulate the stability of R subunits by ubiquitin-
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proteasome pathway. So the principal aim of my work has been to 
identify the role of praja2 as a new important regulator of PKA 
stability and activity, and of the cAMP signalling transmission 
pathway . 
Therefore, I focused my work at: 
 Verify the existence of PKA-praja2 complex.  
 Demonstrate that E3 ligase praja2 ubiquitinates and 
regulates R subunits stability.  
 Defining the biological relevance of praja2 activity in 
regulating cAMP signalling transmission. 
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RESULTS 
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2.1 praja2 and RII form a stable complex  
To identify novel PKA interacting proteins a rat cDNA library was 
screened by yeast two hybrid using mouse full-length RIIα as bait. 
One positive clone (RBP33) of the screen encoded an open reading 
frame of 178-amino acids corresponding to residues 531-708 of 
rat praja2 (also named Neurodap1)(Yu et al., 2002; Nakayama et 
al., 1995)(Fig. 7A). praja2 belongs to the family of RING proteins 
that function as E3 ubiquitin ligases that target cellular substrates 
for proteasomal degradation (Yu et al., 2002).  
Moreover we investigated whether endogenous praja2 and R 
subunits interact in cell extracts. Lysates from HEK293 cells were 
immunoprecipitated with anti-RII or non-immune IgG. 
Precipitates were immunoblotted with anti-RII or anti-praja2 
polyclonal antibody. As shown we detected an endogenous 
praja2-RII complex (fig. 7B). 
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Figure 7. praja2 binds PKA R subunits. (A) Schematic representation of 
human praja2 and its rat homolog neurodap1 (NDAP1, accession # 
NP_620251). Cysteine-rich region (RING) and the C-terminal rat clone 33 
isolated by yeast two-hybrid are shown. RBD, R-binding domain. 
Sequence of the RING-H2 domain of human praja2 along with the 
consensus sequence (boxed residues) are shown. Cysteines 634 and 671 
substituted with alanines are indicated. (B) Lysates (2mg) from HEK293 
cells were immunoprecipitated with anti-RIIor non-immune IgG. 
Precipitates were immunoblotted with anti-RIIor anti-praja2 
polyclonal antibody. 
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2.2  Mapping the PKA binding domain on praja2 
To determine if praja2 ligase activity is required for RII binding, 
HEK293 cells were transiently transfected with flag tagged praja2 
and flag tagged praja2 inactive mutant carrying an alanine 
substitution of two critical residues within the RING domain 
(cys634 and cys671) (praja2rm). Since praja2 promotes 
degradation of R subunits (see below), cells were treated for 15 
hours with the proteasome inhibitor MG132 and lysates were 
immunoprecipitated with anti RIIantibody. praja2 ligase 
activity is unnecessary for RII binding since praja2rm binds RII, 
even more avidly than wild type praja2 (Fig. 8A). As control, we 
used praja2 deleted of the residues 531-708 (see below).  
Furthermore, praja2 also binds RI subunits (Fig. 8B). To identify 
the domain of the protein that mediates binding with R, we 
generated a series of praja2 deletion mutants. Flag-tagged praja2 
mutants were co-expressed with HA-RI in HEK293 cells treated 
for 15 hours with MG132. Lysates were immunoprecipitated with 
anti-RI antibody. We found that residues 531 to 631 of praja2 are 
required for optimal binding to RI (Fig. 8B).  
PKAc was also present in the praja2 complex (Fig. 8C), presumably 
through interaction with R subunit, since deletion of the R binding 
domain of praja2 (residues 531-631) drastically reduced the 
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amount of flag-praja2 recovered in the PKAc immunoprecipitates 
(Fig. 8C). 
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Figure 8. praja2 531-631 residues mediate the binding to R subunits. 
(A) praja2-flag, its RING mutant (Cys634,671Ala) or deletion mutant 
(-708) were transiently transfected in HEK293 cells. Lysates were 
immunoprecipitated with anti-RIIand immunoblotted with anti-flag 
and anti-RII antibodies (lower gels). (B) praja2-flag or its deletion 
mutants (631-708, 531-708 and 31-708) were expressed, along 
with HA-tagged RI, in HEK293 cells. Lysates were subjected to co-
immunoprecipitation with anti-RI and immunoblotted with anti-
RIanti-HA  and anti-flag antibodies. (C) Lysates from praja2-flag (wild 
type and mutants) transfected cells were immunoprecipitates with anti-
PKAc antibody and immunoblotted with anti-PKAc and anti-flag 
antibodies. 
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2.3  praja2 directly interact with Rs 
praja2 directly interacts with R subunits. Thus, a fusion protein 
carrying the full-length praja2 appended to the C-terminus of 
glutathione S-transferase polypeptide (GST) pulled down in vitro 
translated 35S-labeled R subunits (Fig. 9A), as well as endogenously 
expressed RIIand RI subunits (Fig. 9A). Residues 531-631 of 
praja2 are necessary and sufficient to bind R subunits in vitro (Fig. 
9B). 
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Figure 9. praja2 directly interacts with R subunits in vitro. (A) In vitro 
translated, 35S-labeled RII and RI subunits were subjected to pull-
down assays with purified GST-praja2, GST-531-708 and GST-531-631 
fusions. (B) Cell lysates (2 mg) were incubated with purified GST-praja2 
or GST polypeptide. GST beads-bound and input (5%) fractions were 
immunoblotted (or WB as shown in figure) with anti-RIand anti-RII. 
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2.4  praja2 is an A-Kinase Anchor Protein  
Computational sequence analysis of praja2 predicted the presence 
of a highly conserved amphipathic −helical wheel (prototypical 
AKAPs R-binding domain) at position 583-600 that may coordinate 
the binding to R subunits (Beene et al., 2007; Tasken et al., 2004). 
As predicted, a synthetic peptide spanning this domain efficiently 
competed in overlay assay RIIbinding to two prototypic PKA 
binding proteins, MAP2c (Rubino et al., 1989) and AKAP75 
(Bregman et al., 1991) (Fig. 10A). As control, we used a peptide 
carrying proline residues within the amphipathic helix.  
The AKAP binding domain resides at the N-terminus of R subunits 
(residues 1-30) (Feliciello et al., 2001). To test if praja2 binds to the 
AKAP-binding domain of an R subunit, we performed GST-praja2 
pull-down assays in the presence of a molar excess of a 
polypeptide (AKAP121200-450) containing the R binding domain of 
mitochondrial AKAP121. AKAP121200-450 competed the RII binding 
to praja2 (Fig. 10B), indicating that simultaneous RII binding to 
AKAP121 and praja2 is impossible.  
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Figure 10. praja2 amphipathic −helical wheel co-ordinate binding to 
RII. (A) Primary sequence of the residues 583-600 of human praja2 along 
with helical wheel representation. Hydrophobic face in bold. 1 g of 
recombinant MAP2c and AKAP75 were loaded on SDS-PAGE, transfered 
to nylon membrane and overlayed with purified RIIng/ml), in 
presence or absence of praja2 peptide (1M), either wt (pep-wt) or 
proline mutant (pep-pro). After extensive washes in binding buffer, 
bound RIIwas revealed by immunoblot analysis with anti- 
RIIantibody. (B) HEK293 lysates were subjected to pull down assay 
using GST-praja2. Where indicated, molar excess (20) of recombinant 
AKAP121 poliptide (AKAP121200-450) was added to the lysate. Bound and 
input fractions were immunoblotted with the indicated antibodies. 
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2.5 praja2 distribution in rat brain  
We next performed colocalization studies of these and related 
endogenous proteins in neurons. praja2 is widely distributed in 
neurons of most regions of the mammalian brain and accumulates 
within cytoplasmic organelles and at postsynaptic densities (PSDs) 
of axosomatic synapses (Nakayama et al., 1995). Interaction with 
AKAPs concentrates RII into the soma and dendrites of many 
types of neurons in the olfactory bulb, basal ganglia, striatum, 
cerebral cortex, and other forebrain regions (Tunquist et al., 2008; 
Zhong et al., 2009). Accordingly, we analyzed the distribution 
patterns of praja2, RII and calmodulin-dependent kinase II 
(CaMKII) in different rat brain areas. CaMKII is a signalling 
enzyme abundantly expressed in neurons that selectively define 
PSDs (Zhou et al., 2009). praja2 and CaMKII share a similar 
expression profile and intracellular distribution in most of the 
neurons from different brain regions, including cortex, corpus 
striatum, hippocampal subregions CA1 and CA3 and dentate gyrus 
(DG) (Fig. 11A). praja2 is abundantly expressed in pyramidal 
neurons and in the CA3 region of apical dendrites, whereas RII is 
present in a few pyramidal neurons and mostly in mossy fibers 
(Fig. 11B). Moreover, praja2 and RIIsignals are partly co-
distributed in dentate granule cells.  
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Figure 11. Distribution of praja2, CaMKII and RII in rat brain. (A) 
distribution of praja2 and CaMKII in the brain. Sections from cerebral 
cortex (Cx), striatum (Str), hippocampus (CA1, CA3) and dentate gyrus 
(DG) were doubly immunostained with anti-praja2 and anti-CaMKII 
antibodies. Images were collected by confocal microscopy. Scale bar= 50 
m. (B) Sections from CA3 and dentate gyrus (DG) were double 
immunostained with anti-praja2 and anti-RII antibodies. Images were 
collected by confocal microscopy. Scale bar: 50 m. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44 
 
2.6  Endogenous praja2 and RII colocalize in neuronal 
cells 
Colocalization of RII subunits and praja2 was investigated by in situ 
immunostaining of primary hippocampal neurons. Triple 
immunofluorescence staining using anti-praja2, anti-RII and anti-
CaMKII antibodies, demonstrates a partial colocalisation of 
praja2, RIIand CaMKII signals at postsynaptic sites (Fig. 12A). 
We also investigated colocalization of endogenous RII and praja2 
in human neuroblastoma cells (SHSY-5Y). Immunostaining using 
anti-praja2 and anti-RII antibodies shows colocalization signal of 
these proteinsat Golgi-centrosome and partial colocalization at 
plasma membrane and some tiny vescicules in cytoplasm (Fig. 
12B). 
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Figure 12. praja2 and RII colocalize in neuronal cells. (A) Primary 
hippocampal neurons were subjected to triple immunofluorescence with 
rabbit polyclonal anti-praja2, monoclonal mouse anti-CaMKII and goat 
polyclonal anti-RII antibodies. Right panels: profile plots are referred to 
the cross line shown in the panels and express the intensity (a.u., 
arbitrary units) of fluorescence from left to right. Lower panels: 
Pearson’s coefficients between praja2, RII and CaMKII. Scale bar: 10 
m. (B) immunostaining showing coexpression of praja2 and RIIin 
human neuroblastoma cells SHSY-5Y. Colocalization Pearson’s 
coefficient praja2-RII. Scale bar: 20 m. 
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2.7 Expression of exogenous praja2 redistributes 
endogenous RII subunits  
Next we investigated colocalization of RII subunits and exogenous 
praja2 by in situ immunostaining of human neuroblastoma cells 
(SHSY-5Y). Expression of flag-praja2 redistributed RII subunits from 
the Golgi-centrosome area to the cytoplasm and cell membrane, 
compared to control untransfected cells, and partial colocalization 
of praja2-flag and RII signals could be assigned (Fig. 13A). As 
controls, praja2 mutant lacking the PKA binding domain (Δ531-
708-flag) was used (Fig. 13A). Similarly, a praja2-GFP fusion 
promoted relocalization of RII subunits (in HEK293 cells) from 
intracellular pools to focal points at the plasma membrane, where 
both signals overlapped (Fig. 13B, upper panels). No significant 
changes of R localization were evident in cells transfected with 
GFP (Fig. 13B, lower panels). 
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Figure 13. Exogenous praja2 relocalize RII to the plasma membrane. (A) 
Human neuroblastoma cells (SHSY-5Y) were transiently transfected with 
praja2-flag or its deletion mutant (531-708). 24 hours from 
transfection, cells were fixed and doubly immunostained with anti-
RII/ and anti-flag antibodies. 12 hours before harvesting cells were 
treated with MG132 (10M). Fluorescent images were collected and 
analyzed by confocal microscopy. A merged composite is shown. Scale 
bar: 20 m. (B) HEK293 cells were transiently transfected with praja2-
GFP (upper panels) or GFP (lower panels). 24 hours from transfection, 
cells were fixed and immunostained with anti-RII. Scale bar: 20 m. 
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2.8 praja2 induces proteolysis of R subunits  
We hypothesized that praja2, as an E3 ligase, should destabilise R 
subunits. To confirm this idea, HEK293 cells were transiently co-
transfected with expression vectors encoding praja2-flag and with 
hemaglutinin (HA)-tagged RII (Fig. 14A), myc-RII (Fig. 14B) or 
HA-RI (Fig. 14C), and results analysed by immunoblot. Indeed, 
wild type praja2 or a praja2 mutant carrying cysteine 634 
substituted to alanine significantly reduced the levels of co-
expressed R subunits. In contrast, the concentrations of R subunits 
in cells expressing praja2rm were similar to those of control cells. 
praja2-induced degradation of RI subunits was reversed by 
MG132 (Fig. 14D), indicating that praja2-dependent Rs 
degradation is mediated by proteasome. Similarly, endogenous 
RIIand RI subunits were degraded by overexpressed praja2-
flag, but not by the praja2-flag RING mutant (Fig. 14E). 
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Figure 14. praja2 triggers degradation of R subunits. (A-C) HEK293 cells 
were transiently co-transfected with HA-RII (A), myc-RII (B) or HA-RI 
(C) and praja2-flag expression vectors. In (A), two RING mutants were 
used: praja-Cys634A and praja2rm. 24 hours following transfection, cells 
were harvested and lysed. Lysates were immunoblotted with the 
indicated antibodies. (D) Same as (C), except the cells were treated for 8 
hours with MG132 (20M) before harvesting. (E) Immunoblot analysis of 
endogenous R subunits on lysates from cells transiently transfected with 
praja2-flag vectors. ERK2 was used as loading control.  
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2.9 praja2 ubiquitinates RII subunits   
E3 ubiquitin ligase praja2 triggers R subunits degradation, so we 
next asked if praja2 ubiquitinates R subunits. HEK293 cells were 
co-transfected with praja2-flag, praja2rm-flag, myc-RIIand HA-
ubiquitin vectors. Cells were treated with MG132 and lysates 
were immunoprecipitated with anti−myc antibody and 
immunoblotted with anti-HA, anti-RII and anti-flag antibodies. 
Expression of praja2, but not of praja2rm, induced accumulation 
of poly-ubiquitinated myc-RII (Fig. 15A). Since degradation of RII 
by praja2 is enhanced by cAMP (see below), we determined if 
praja2 was required for RII ubiquitination in forskolin-stimulated 
cells. In control cells, immunoprecipitated RIIubiquitination 
was potentiated by forskolin (synthetic adenylyl cyclase activator) 
and IBMX (3-isobutyl-1-methylxanthine, phosphodiesterase 
inhibitor) treatment (Fig. 15B). Depletion of endogenous praja2 
using specific siRNA, drastically reduced RII ubiquitination, 
both in untreated and forskolin stimulated cells. An in vitro 
ubiquitination assay confirmed that RII is, indeed, a direct 
substrate of praja2 (Fig. 15C). In contrast, praja2rm and a praja2 
mutant lacking the PKA phosphorylation sites (S342A, T389A, see 
below) failed to ubiquitinate RII in vitro. 
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Figure 15. praja2 ubiquitinates RIIsubunits. (A) HEK293 cells were 
transfected with HA-ubiquitin, RII-myc and praja2 or praja2rm. 24 
hours after transfection, cells were treated with MG132 (20 μM) for 8 
hours. Lysates were immunoprecipitated with anti−myc and 
immunoblotted with anti-HA, anti-RII and anti-flag antibodies. (B) 
HEK293 cells were transfected with HA-tagged ubiquitin. Where 
indicated, control (siRNAc) or SMARTpool siRNApraja2 (siRNApraja2) 
was included in the transfection mix. 24 hours after transfection, cells 
were either left untreated or stimulated with forskolin (40 μM) and 
IBMX (0.5 mM) for 3 hours, in the presence of MG132 (20 μM). Lysates 
were immunoprecipitated with anti-RII and immunoblotted with 
anti-HA, anti-RII and anti-praja2 antibodies. Arrow indicates 
endogenous praja2. (C) In vitro translated, 35S-labeled RII was 
incubated with his6-tagged ubiquitin, in the presence or absence of E1, 
UbcH5c (E2) and anti-flag precipitates from HEK293 extract transiently 
transfected with praja2-flag, praja2rm-flag or S342A, T389A-flag. The 
reaction mix was denatured, size-fractionated on 7% SDS-PAGE, and 
analyzed by autoradiography. A fraction of the reaction mixture was 
immunoblotted with anti-flag antibody (lower panel). 
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2.10 Regulated binding of PKA to praja2 by cAMP 
signaling  
Ubiquitination and consequent proteolysis of R subunits by praja2 
are stimulated by cAMP, suggesting that dissociation of PKA 
holoenzyme is a prerequisite for R degradation. Regulation of 
praja2 activity by PKAc might also contribute to proteolytic 
turnover of R subunits. To address this issue, we performed 
immunostaining analysis of PKAc in neurobloastoma cells SHSY-5Y 
overexpressing praja2. praja2 redistributed PKAc from the Golgi-
centrosome area to the cytoplasm and plasma membrane (Fig. 
16A). We also performed coimmunoprecipitation assays to 
confirm that PKAc interacts with praja2. A praja2•PKAc complex 
could be isolated from serum-deprived cells (Fig. 16B). Forskolin 
treatment increased the amount of PKAc recovered in the anti-
praja2 precipitates. This effect was reversed by pre-treating the 
cells with H89, a potent PKA inhibitor. In addition, forskolin 
triggered complex formation of praja2•PKAc resulted in 
phosphorylation of praja2 by the associated kinase (Fig. 16B, 
lower panels). We then performed an independent test to verify 
the cAMP-dependent interaction of PKA with praja2. Thus, cAMP-
coupled agarose beads co-precipitated endogenous PKA 
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holoenzyme in complex with overexpressed praja2-flag (Fig. 16C 
and Fig. 16D). 
The resin-coupled cAMP analogue competes with endogenous 
cAMP in binding to R subunits, preventing dissociation of PKA 
holoenzyme by forskolin or isoproterenol treatment. As a negative 
control we added excess cAMP (5mM) to mask the cAMP binding 
sites in the R subunits for precipitation (Fig. 16E). Under basal 
conditions, overexpressed praja2-flag (Fig. 16E and Fig. 16F)  were 
coprecipitated with endogenous R-PKAc complexes. However, pre-
treating the cells with forskolin or isoproterenol for 15 minutes 
increased the amount of recovered PKA•praja2-flag complexes 
(Fig. 16E and Fig. 16F). These results confirm the idea that praja2 
forms stable complexes with the PKA holoenzyme and that cAMP 
elevation further enhances the formation of the PKA•praja2 
complex. 
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Figure 16. PKA-praja2 regulated interaction. (A) SHSY-5Y cells were 
transiently transfected with praja2-flag or 531-708-flag vector and 
immunostained with anti-flag and anti-PKAc antibodies. (B) Lysates from 
HEK293 cells expressing praja2-flag and treated with MG132 for 12 hr 
were immunoprecipitated with anti-flag antibody. The precipitates were 
immunoblotted with the indicated antibodies. Where indicated, cells 
were treated with forskolin (Fsk 40 M) and IBMX (0.5 mM) for 30 min 
before harvesting, in absence or presence of H89 (10 M). (C) Schematic 
structure of the cAMP analog, Rp-8-AHA-cAMP. (D) Schematic 
illustration of the cAMP precipitation strategy: Resin coupled cAMP 
analogue binds endogenous R subunits and promotes PKA holoenzyme 
re-association following forskolin (Fsk) or isoproterenol (Iso) treatment 
(R•PKAc; AC, adenylyl cyclase). (E) cAMP precipitation of endogenous 
PKA subunits using cAMP agarose resin (Rp-8-AHA-cAMP) from 2AR 
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HEK293 cells transiently expressing praja2-flag in response either to 15 
min of forskolin (100 M) or isoproterenol (10 M) treatment. In the 
negative control experiment we added excess of cAMP (5 mM) to the 
lysates to mask the cAMP binding sites in the R subunits. Immunoblot 
analysis was done with anti-RII, anti-PKAc and anti-flag antibodies. (F) 
Densitometric quantification of the fold enrichment of complex 
formation of R subunits and praja2 in response to forskolin and 
isoproterenol. Results are presented as means ± S.E.M. from three 
independent experiments. 
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2.11 PKAc phosphorylates praja2 at Ser342 and Thr389 
We assessed if praja2 is a substrate of PKAc. Primary sequence 
analysis predicts the presence of two PKA phosphorylation sites 
within the core region of praja2 (Ser 342 and Thr 389) (Fig. 17A, 
upper panel). HEK293 cells transiently transfected with praja2-flag 
or praja2 S342A,T389A mutant were treated with forskolin and 
lysates were immunoprecipitate with anti-flag antibody and 
immunoblotted with phosphoSer/Thr PKA substrates and flag 
antibodies. Substitution of both residues with alanine (S342A, 
T389A) inhibited forskolin-induced praja2 phosphorylation (Fig. 
17A, lower panels). In vitro kinase assays demonstrated that 
purified PKAc directly phosphorylates immunoprecipitated wild 
type praja2, but not the S342A, T389A mutant, confirming these 
residues as the major PKA phosphorylation sites (Fig. 17B). 
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Figure 17. PKAc phosphorylates praja2 at Ser342 and Thr389. (A) 
Schematic diagram of praja2, including protein sequence surrounding 
the putative PKA consensus sites. Serine 342 and Threonine 389 are 
underlined. HEK293 cells transiently transfected with empty vector 
(CMV), praja2-flag or praja2 S342A,T389A mutant were serum deprived 
overnight and treated with forskolin (40 M) and IBMX (0.5 mM) for 30 
min before harvesting. Lysates were immunoprecipitates with anti-flag 
antibody and immunoblotted for the detection of phosphoSer/Thr PKA 
substrates and flag antibodies. (B) praja2-flag and its mutant praja2 
S342A,T389A were immunoprecipitated from cell lysates. The 
precipitates were incubated in kinase buffer for 10 min with purified 
PKAc and ATP/[32P]-ATP and resolved on SDS-PAGE. [32P]-labeled praja2 
was visualized by autoradiography. An aliquot of the samples was 
immunoblotted with anti-flag antibody. 
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2.12 Phosphorylation of praja2 is required for R 
degradation  
cAMP signaling stimulation induces Rs degradation by praja2 
ubiquitination and our data reveal that PKAc directly 
phosphorylates praja2. This events suggest a crucial role of PKAc 
mediated phosphorylation of praja2 in activating praja2 E3 ligase 
activity. To address this event we performed  co-
immunoprecipitation assays using HEK293 cells transiently 
transfected with praja2-flag or praja2 S342A,T389A mutant and 
treated with forskolin or left untreated. Lysates were 
immunoprecipitate with anti-RII antibody. These experiments 
confirmed that praja2 phosphorylation is required for its cAMP-
mediated interaction with R subunits (Fig. 18A). Moreover, 
expression of S342A, T389A mutant stabilizes RII subunits, even in 
cells stimulated with forskolin and IBMX (Fig. 18B). This implies 
that PKA activity regulates the abundance of compartmentalized 
pools of R subunits via praja2 phosphorylation and recruitment to 
R subunits, leading to subsequent R proteolysis. 
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Figure 18. PKAc mediated phosphorylation of praja2 activate E3 ligase 
activity. (A) HEK293 cells transiently transfected with the indicated 
vectors were serum-deprived overnight and stimulated with forskolin 
(40M) for 30 min. Lysates were immunoprecipitated with anti-RII 
antibodies. Precipitates and lysates were immunoblotted anti-RII and 
anti-flag antibodies. (B) Lysates from serum-deprived and forskolin-
treated (40M) cells transiently co-transfected with HA-RIIand empty 
vector (CMV), praja2-flag or praja2 S342A,T389A mutant were 
immunoblotted with anti-HA and anti-flag antibodies. ERK2 was used as 
loading control. 
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2.13 praja2 regulates PKA-induced CREB 
phosphorylation in cells 
The coupling of adenylate cyclase activation at the cell membrane 
to mRNA induction involves dissociation of PKA holoenzyme, 
translocation of PKAc to the nucleus, phosphorylation of the 
transcription factor CREB at Ser133 and 
phosphoCREB/coactivator-dependent activation of nuclear gene 
transcription (Lonze et al., 2002; Feliciello et al., 1997). The data 
shown above indicate that praja2 mediates cAMP-dependent 
degradation of R subunits, prolonging the time of PKAc activation. 
Thus, we would predict that depletion of praja2 decreases PKAc 
signalling to nuclear targets (i.e. CREB). Endogenous praja2 was 
depleted by transfecting siRNApraja2, as confirmed by 
immunofluorescence (Fig. 19A) and immunoblot analyses (Fig. 
19B). In control cells, most RII staining was concentrated at the 
Golgi-centrosome area and the perinuclear region. praja2 down-
regulation dispersed RII throughout the cytoplasm (Fig. 19A). The 
physiological significance of praja2 down-regulation on nuclear 
cAMP signalling was evaluated by analysis of CREB 
phosphorylation at Ser133 in situ. In control cells, forskolin 
stimulation increased the number of phosphoSer133-CREB 
positive nuclei in a time-dependent manner (Fig. 19B and Fig. 
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19C). In contrast, a nearly two-fold decline in phosphoSer133-
CREB positive nuclei was seen in cells transfected with 
siRNApraja2 at both time points of forskolin stimulation. Down-
regulation of praja2 by siRNApraja2 prevented the forskolin-
induced decline of RII subunits and inhibited CREB 
phosphorylation (Fig. 19D and Fig. 19E). Coexpression of praja2-
flag, but not of its mutant Δ531-708, reversed the effects of 
siRNApraja2 (Fig. 19F). 
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Figure 19. praja2 controls PKA signalling. (A) Double 
immunofluorescence for praja2 and RII in human neuroblastoma cells 
SHSY-5Y transiently transfected with siRNAc or siRNApraja2. Scale bar: 
20 m. Scale bar: 20 m. (B) 24 hours from transfection, cells were 
serum deprived overnight and stimulated with forskolin (40 M) and 
IBMX (0.5 mM) for 30 min and 60 min. Formalin-fixed cells were 
immunostained with anti-phosphoSer133 antibody. Immunoblots (lower 
panels) show the expression of praja2 in siRNAc (lanes 1, 2) and siRNA-
transfected (lanes 3, 4) cells, left untreated (lanes 1, 3) or stimulated 
with forskolin for 60 min (lanes 2, 4). (C) Quantitative analysis of the 
experiments shown in B. The data are expressed as mean ± S.E.M. of 
three independent experiments made in triplicate. 200-250 cells were 
scored in each set of experiments. *P <0.01 versus control (siRNAc). (D) 
Lysates from control (siRNAc) or siRNApraja2-transfected cells were 
serum deprived overnight. Before harvesting, cells were left untreated 
or stimulated with forskolin (Fsk) (40M) and IBMX (0.5mM) for the 
indicated times. Lysates were immunoblotted with the indicated 
antibodies. (E) Immunoblot analysis of lysates from control (siRNAc) or 
siRNApraja2-transfected cells. Before harvesting, cells were serum 
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deprived overnight and left untreated or stimulated with forskolin (Fsk) 
(40M) and IBMX (0.5mM) for 30 min. Where indicated, praja2-flag 
vectors (wild type and its mutant 531-708) were included in the 
transfection mixture. Lysates were immunoblotted with the indicated 
antibodies. 
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2.14 praja2 regulates PKA-induced c-fos transcription in 
cells 
Transcription of c-fos is mediated by binding of CREB to an 
upstream cAMPresponsive element (CRE). CREB phosphorylation 
at Ser133 drives c-fos transcription (Montminy, 1997). We 
monitored the effects of praja2 down-regulation on c-fos mRNA 
synthesis. In control (siRNAc) cells, low levels of c-fos mRNA were 
detected under basal conditions. Activation of adenylate cyclase 
by isoproterenol (-agonist hormone) induced a robust and 
persistent increase of c-fos mRNA at 30 min and 60 min following 
treatment (Fig. 20A). Induction of c-fos mRNA was reduced 
several-fold in siRNApraja2-transfected cells. Similar effects on c-
fos transcription by siRNApraja2 were observed in cells that were 
stimulated with forskolin (Fig. 20B). Rescue experiments 
confirmed the role of praja2 phosphorylation and activity in the 
control of cAMP-induced gene transcription. Thus, co-expression 
of wild type praja2, but not of its mutants (praja2rm and S342A, 
T389A), rescued c-fos mRNA accumulation in siRNApraja2-
transfected cells, at both 60 min and 120 min of stimulation with 
forskolin (Fig. 20B). Moreover, co-expression of PKAc bypassed 
the block imposed by siRNApraja2 and partially restored c-fos 
levels. These findings strongly suggest that down-regulation of R 
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subunit by praja2 prolongs the wave of PKAc activation and 
positively impacts on downstream signalling. 
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Figure 20. praja2 controls PKA-dependent transcription. (A-B) 
Quantitative RT-PCR showing c-fos accumulation in HEK293 cells 
transfected with siRNAc or siRNApraja2 and stimulated with 
isoproterenol (1M) (A) or forskolin (40M) and IBMX (0.1 mM) (B) for 
the indicated time points. Data represent a mean value ± S.E.M. from 
two independent experiments made in triplicate. Where indicated, 
vectors for praja2, praja2 S342A,T389A, praja2rm and PKAc were 
included in the transfection mixture. *P <0.01 versus control (siRNAc). 
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2.15 praja2 silencing impairs nuclear cAMP signaling in 
rat brain 
praja2 is abundantly expressed in mammalian brain (Nakayama et 
al., 1995) (see above). This prompted us to investigate if down-
regulation of praja2 in intact brains would affect nuclear PKAc 
signalling. siRNApraja2 or siRNAc were perfused intracerebro-
ventricularly (icv) in rats (Fig. 21A). Intracerebral infusions of 
siRNApraja2 reduced praja2 levels in areas surrounding the 
perfused hemispheres (striatum and hippocampus) (Fig. 21B). 
Functional consequences of praja2 down-regulation on cAMP-PKA 
signalling were evaluated by CREB phosphorylation and c-fos 
transcription in striato-hippocampal areas. Significant amounts of 
basal phosphoSer133-CREB were evident in control rat brain (Fig. 
21B and Fig. 21C). CREB phosphorylation modestly increased at 30 
min after icv infusion of isoproterenol and declined in the next 30 
min. In vivo silencing of praja2 reduced CREB phosphorylation by 
about two-fold, both under basal conditions and with 
isoproterenol treatment. In situ immunohistochemistry confirmed 
the inhibition of CREB phosphorylation in the hippocampal area of 
siRNApraja2-perfused rat brain, compared to controls (Fig. 21D 
and Fig. 21E). Inhibition of CREB phosphorylation by siRNApraja2 
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provoked a significant down-regulation of isoproterenol-induced 
c-fos transcription (Fig. 21F). 
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Figure 21. praja2 controls nuclear cAMP signaling in rat brain. (A) 
Schematic diagram showing intraventricular siRNAs administration in rat 
brain. Three sequential siRNAs infusions were employed (time points: 0 
h, 10 h, 22 h). 24 hours later, isoproterenol was icv infused. Rats were 
sacrified following 30 min and 60 min isoproterenol exposure. (B) 
Immunoblot analysis of lysates from hippocampal/striatal regions of rat 
brain intraventricularly perfused with siRNAs and subsequently treated 
with isoproterenol for the indicated time points. Lysates were 
immunoblotted with the indicated antibodies. (C) Quantitative analysis 
of phosphoCREB from the experiments shown in (B). The data are 
expressed as mean ± S.E.M. of three experiments. (D) Sections from 
hippocampal regions of rat brain perfused with siRNAs and treated with 
isoproterenol as in (C) were doubly immunostained with anti-
phosphoCREB and anti-NeuN antibodies. The images were collected and 
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analysed by confocal microscopy. Scale bar: 50 m. (E) Quantitative 
analysis of the experiments shown in (D). The data are expressed as 
mean ± S.E.M. of two independent experiments. 300-350 cells were 
scored in each set of experiments. *P <0.05 versus control (siRNAc). (F) 
Quantitative RT-PCR showing c-fos accumulation in the striatum. Data 
represent a mean value ± S.E.M. from two independent experiments 
made in duplicate that gave similar results. *P <0.01 versus control 
(siRNAc). 
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2.16 praja2 silencing impairs L-LTP in rat brain  
Finally, we investigated the electrophysiological consequences of 
praja2 down-regulation by monitoring LTP at perforant pathway to 
granule cell synapses (PP-DG). Firstly, we studied the early, PKA-
independent, phase of LTP (E-LTP) induced by one train of HFS 
(Malleret et al., 2010). We found similar E-LTP in both siRNAc and 
siRNApraja2-treated rats (50–60 min post-HFS: siRNAc, 155 ± 21%; 
siRNApraja2, 161 ± 9%, p> 0.05) (Fig. 22A). Next, we studied the 
late phase of LTP (L-LTP), that typically requires the activation of 
cAMP-PKA (Malleret et al., 2010), by using a theta burst 
stimulation (TBS) pattern. Interestingly, this protocol reliably 
induced sustained L-LTP in controls but not in siRNApraja2-treated 
rats (150–160 min post-TBS: siRNAc, 177 ± 11%; siRNApraja2, 123 
± 11%, p< 0.05) (Fig. 22B). These results suggest that praja2 
activity is essential for long-term memory processes.  
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Figure 22. praja2 controls cAMP-dependent L-LTP formation in rat 
brain. (A) The early phase of LTP (E-LTP) induced by one train of HFS is 
comparable between siRNAc (white squares) and siRNApraja2-rats (grey 
triangles). fEPSP amplitudes are expressed as percentage of pretetanus 
baseline. (B) Time plot of field excitatory post-synaptic potential (fEPSP) 
responses for group data, showing that TBS protocol elicits normal LTP 
in siRNAc-rats (white squares), but deficient LTP in siRNApraja2-rats 
(grey squares). fEPSP amplitudes are expressed as percentage of 
pretetanus baseline. 
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Activation of PKA is rapidly followed by a refractory period during 
which ligand-stimulated cells become less responsive to the next 
cAMP wave. Phosphodiesterases, Ser/Thr phosphatases and 
transcriptional regulation of components of the cAMP signaling 
cascade control the establishment and maintenance of the 
refractory period (Houslay et al., 2007; Canettieri et al., 2003; 
Armstrong et al., 1995). 
The relative abundance of R and PKAc subunits also contributes to 
the strength and duration of cAMP signalling. For example, 
increased PKAc activity profoundly alters the sensitivity of cells to 
ligand stimulation, sustaining downstream cAMP signalling and 
impacting on different aspects of cellular behaviour (Davis et al., 
1998; Amieux et al., 2002).  
Deletion of the PKA RII regulatory subunit in mice enhances 
basal activity of PKAc subunits, leading to increased metabolic rate 
in adipose tissue and impairment of neuronal activities (Newhall et 
al., 2005; Cummings et al., 1996). In Aplysia sensory neurons, 
ubiquitin-dependent proteolysis of R subunits facilitates 
downstream PKAc signalling and controls induction and 
consolidation of long-term memory (Chain et al., 1999; Hegde et 
al., 1993). However the E3 ubiquitin-ligase controlling the stability 
of R subunits in eukaryotes was unknown. 
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We have identified praja2 as the E3 ligase that ubiquitinates and 
degrades mammalian R subunits. praja2-PKA complexes optimally 
decode signals generated at cell membranes and rapidly 
propagate the cAMP input to the downstream effector kinase. 
Overexpression of praja2 induces proteolysis of R subunits, 
whereas genetic knock-down of the ligase prevents cAMP-induced 
decline of R subunits levels. Under basal conditions, praja2 
controls the bulk levels of compartmentalized PKA holoenzyme. 
Elevation of cAMP levels increases praja2-PKA complex formation, 
favoring efficient and synchronised local activation of the kinase. 
Phosphorylation of praja2 by PKAc enhances proteolysis of R 
subunits and reduces the stoichiometric ratio of R/PKAc, 
sustaining substrate phosphorylation by the activated Kinase. The 
molecular events controlled by praja2 ultimately impact on the 
amplitude of PKA signalling (i.e. CREB phosphorylation and nuclear 
gene transcription) and significantly contribute to synaptic 
plasticity and long-term memory.  
Collectively, our findings indicate that PKA regulated proteolysis of 
R subunits  by praja2 constitutes an important positive feed-back 
mechanism that controls the rate and magnitude of cAMP-PKA 
signalling. Understanding the intricate connection between 
hormone-generated signals and the ubiquitin-proteasome 
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pathway, and identifying the mechanism(s) underlying cAMP 
signal generation and attenuation at target sites provides basic 
insights into hormone action. 
 
 
 
 
Figure 23. Molecular mechanism model. Under resting conditions, PKA 
holoenzyme accumulates inside the cells as consequence of low 
ubiquitination rate of R subunits. Elevation of intracellular cAMP levels 
by ligand (L) stimulation of the adenylate cyclase (AC) efficiently 
activates PKA, which in turn phosphorylates praja2. Phosphorylated 
praja2 ubiquitinates and degrades R subunits through the proteasome 
pathway. Accumulation of free, active PKAc (C) sustains substrate 
phosphorylation and positively impacts on the amplitude of cAMP 
signalling. 
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Cell lines. Human embryonic kidney cell line (HEK293) and 
neuroblastoma cells (SHSY5Y) were cultured in Dulbecco modified 
Eagle’s medium containing 10% fetal bovine serum in an 
atmosphere of 5% CO2. Where indicated, cells were propagated in 
DMEM medium supplemented with 10% calf serum. Hippocampal 
neurons were prepared from 18 days old rat embryos. Neurons 
were cultured at 37°C in a humidified 5% CO2 atmosphere with 
medium replenishment after 6 days, and used after 11 days of 
culture in all experiments. 
Animals. Female Wistar rats (Charles River) were housed in 
diurnal lighting conditions (12 hours darkness and 12 hours light) 
and fasted overnight but allowed free access to water before the 
experiment. Experiments were performed according to 
international guidelines for animal research and the experimental 
protocol was approved by the Animal Care Committee of the 
University of Naples. 
Plasmids and transfection. Vectors encoding the flag-praja2, GFP-
praja2 and GSTpraja2 were purchased from Genecopeia. praja2rm 
was generated by site-directed mutagenesis, while praja2 deletion 
mutants and GST-fusions were generated by PCR with specific 
oligonucleotide primers. PCR products were subcloned into the 
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same vector of wild-type praja2 cDNA. HA-tagged ubiquitin was 
provided by Dr Antonio Leonardi (University of Naples, Italy); 
epitope tagged RIα and RIIα/β vectors were provided by Dr 
Ginsberg SH (Lim et al., 2007). SMART pool siRNAs targeting 
coding regions and 3’UTR of distinct segments of praja2 and RIIα/β 
were purchased from Dharmacon and Sigma. The siRNAs were 
transiently transfected using Lipofectamine 2000 (Invitrogen) at a 
final concentration of 100 pmol/ml of culture medium. 
Antibodies and chemicals. Rabbit polyclonal antibodies directed 
against RIIβ, RIIα, RIα, PKAc, ERK2, hemaglutinin epitope (HA.11), 
glutathione S-transferase (GST), CaMKIIα were purchased from 
SantaCruz; we also used antibodies directed against RIIβ, RIIα, RIα 
purchased from BD Transduction; α−tubulin, flag and myc epitope 
from Sigma; phosphoser133-CREB and CREB from Millipore; two 
distinct polyclonal antibodies directed against human praja2 were 
generated in rabbit using the following epitopes: 1) residues 480-
631; 2) residues 60-250. Both antibodies gave similar 
immunostaining patterns. Forskolin, isoproterenol and cAMP were 
purchased from Sigma.  
Immunoprecipitation and pull down assay. Cells (or rat tissues) 
were homogenized in lysis buffer (50mMTris-HCl, pH 7.4, 
0.15MNaCl, 100 mM EDTA,0.5% NP40) containing aprotinin (5 
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g/ml), leupeptin (10 g/ml), pepstatin (2 g/ml), and 0.5 mM 
phenylmethylsulfonyl fluoride. The lysates were cleared by 
centrifugation at 15,000 g for 15 min. Cell lysates (2 mg) were 
immunoprecipitated with the indicated antibodies. An aliquot of 
cell lysate (100 g) or immunoprecipitates were resolved by SDS-
PAGE gel and transferred to Protran membrane. The immunoblot 
analysis was performed as previously described. 
Chemoluminescent (ECL) signals were quantified by scanning 
densitometry (Molecular Dynamics, Sunnyvale, CA). GST fusions 
were expressed and purified from BL21 (DE3) pLysS cells. 20 μl of 
GST or GST-praja2 beads were incubated with 2 mg of cell lysate 
or with in vitro translated [35S]-labeled R subunits in 200 μl lysis 
buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.5% 
triton X-100) in rotation at 4 °C overnight. Pellets were washed 
four times in lysis buffer supplemented with NaCl (0.4 M final 
concentration) and eluted in Laemmli buffer. Eluted samples were 
resolved by 8%-PAGE gel, transferred to polyvinyldene difluoride 
membranes and immunoblotted with the indicated antibody. 
In vitro kinase assay and RII-Overlay Analysis. Flag-tagged praja2 
and S342A,T389A mutant transiently expressed in HEK293 cells 
were immunoprecipitated with anti-flag antibody. The precipitates 
were washed twice in kinase buffer (10 mM MgCl2, 20mM Hepes, 
 87 
 
pH 7.4) and resuspended in the same buffer (50 μl) containing 10 
μM ATP, 10 μCi of *γ-32P+ATP (Amersham Corp.), 100 μM cAMP 
and 10 units of purified PKAc (Sigma). Following incubation at 30 
°C for 10 min, samples were washed three times in kinase buffer, 
resuspended in Laemily buffer and loaded on SDS-PAGE. 
Phosphorylated proteins were visualized by autoradiography. An 
aliquot of the samples was immunoblotted with anti-flag 
antibodies. PKAc activity was fully inhibited by adding a specific 
PKA inhibitor peptide (PKI, 10 mM) containing a PKA 
pseudophosphorylation site (Sigma) (data not shown). RII-overlay 
assay was performed as previously described24, with the 
exception that RIIβ-binding proteins were visualized by 
immunoblotting the filter with anti-RIIβ antibody. 
In vitro ubiquitination assay. [35S]-labeled R subunits praja2 were 
synthesized in vitro using TnT quick coupled 
transcription/translation system (Promega) in the presence of 45 
μCi of *35S+-labeled methionine. The ubiquitination assay was 
performed in buffer containing 50 mM Tri-HCl pH 7.5, 0.6 mM 
dithiothreitol, 5mM MgCl2, supplemented with recombinant his-
ubiquitin (2.5 μg/μl), 2 mM ATP, E1 (1.5 ng/μl) (Affinity Research, 
Exeter, UK), purified E2 (10 ng/μl) (UbcH5b) in the presence or 
absence of agarose beads-bound praja2-flag or its mutants 
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immunoprecipitated from cell lysates. The reaction mixture was 
incubated at 30oC for 90 min, then stopped with Laemmli buffer 
and size-fractionated on 8% SDS-PAGE. Ubiquitination products 
were visualized by autoradiography.  
siRNAs administration into the rat brain. All rats, anesthetized 
with chloral hydrate (400 mg/kg, i.p.), were put on a stereotaxic 
frame. A 23-g stainless steel guide cannula (Small Parts, Inc, Miami 
Lakes, FL) was implanted into the right lateral ventricle, the third 
ventricle using the stereotaxic coordinates of 0.5 mm caudal to 
bregma, 2 mm lateral and 2.5 mm below the dura. The cannula 
was fixed to the cranium using dental acrylic and small screws. 
siRNAs targeting praja2 (10μl from 250μM stock) and control 
siRNAs (10μl from 250μM stock) were administered three times, 
24 hours, 12 hours and 1 hour before isoproterenol stimulation. 
Rats were sacrificed 30 min or 60 min later. Distinct brain regions 
(cortex, hippocampus and striatum) from left and right 
hemisphere were isolated. Brain tissues were used for 
immunoblot analysis and RNA extraction. 
RNA purification and quantitative PCR analysis. Total RNA was 
extracted with TRIzol reagent according to the manufacturer’s 
protocol (Sigma, St. Louis, MO, USA). Two micrograms of the 
isolated RNA were reverse-transcribed with the Omniscript RT kit 
 89 
 
(Qiagen, Milan, Italy). Optimal reverse-transcriptase reactions 
were performed in 20 μl volume consisting of 10X buffer, 1 IU of 
reverse transcriptase, 10 IU of RNase OUT, 2 mM dNTPs, and 1mM 
random examers at 37°C for 1 h. Real time PCR was performed in 
triplicate in 20 μl reaction volumes using the Power SYBER Green 
PCR Master Mix (Applied Biosystems, Foster City, CA, USA). PCR 
primers for human c-fos mRNA are the following: forward 5’- 
CGGGCTTCAACGCAGACTA; reverse 5’- 
GGTCCGTGCAGAAGTCCTG, while for rat c-fos mRNA we used the 
following primers: forward 5’-AGCATGGGCTCCCCTGTCA; reverse 
5’- GAGACCAGAGTGGGCTGCA. Primers were used at final 
concentration of 4 μM. 18S RNA was used as reference. Real time 
PCR reactions were carried out in a MJ MiniTM Personal Thermal 
Cycler apparatus (Bio-Rad Laboratories, CA, USA). Melting curves 
were obtained by increasing the temperature from 60°C to 95°C 
with a temperature transition rate of 0.5°C/sec. Melting curves of 
final PCR products were analysed (OpticonMonitor 3 Bio-Rad). 
Confocal microscopy and image analysis. Forebrain coronal 
vibratome sections were subjected to immunostaining with 
incubated anti-RIIβ, anti-praja2 and anti-CaMKIIα antibodies. 
Immunofluorescence was visualized using a Zeiss LSM 510 Meta 
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argon/krypton laser scanning confocal microscope. Four images 
from each optical section were averaged to improve the signal to 
noise ratio. A minimum of four sections per brain and four 
different samples per region were analyzed. Cultured cells 
transiently transfected with expression vectors were fixed and 
immunostained with anti-RIIα/β, anti-PKAc, antiflag or anti-praja2 
antibodies. Confocal analysis was performed as above. 
cAMP precipitation. β2AR HEK293 cells transiently overexpressing 
praja2 fusion proteins have been treated with indicated stimuli, 
were lysed and subjected to precipitations with Rp-8-AHA-cAMP 
agarose resin (Biolog) for two hours. In this assay, binding of R 
subunits to the resin-coupled cAMP analogue (= PKA inhibitor Rp-
cAMP, inhibits holoenzyme dissociation) results in re-association 
of activated PKAc and R subunits. To test the impact of cAMP on 
the complex formation of PKA•praja2 we artificially elevated 
endogenous cAMP levels with forskolin or through activation of 
the stably expressed beta2-adrenergic receptor (β2AR) by 
isoproterenol prior to cell lysis. As control we have added excess 
of cAMP (5mM) to mask the cAMP binding sites in the R subunits 
for precipitation. Resin associated complexes have been washed 
at least four times with the lysis buffer (10 mM sodium phosphate 
pH 7.2, 150 mM NaCl, 0,5% Triton X100 supplemented with 
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standard protease inhibitors) and eluted with Laemmli sample 
buffer and subjected to immunoblot analysis.  
Electrophysiology. All animal procedures were in compliance with 
the European Council Directive (86/609/EEC). Parasagittal 
hippocampal slices (400 μm) from rats treated with siRNAs 
targeting praja2 and control siRNA were kept submerged at 30 ºC 
and superfused (2–3 mL/min) with oxygenated (95% O2, 5% CO2) 
artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 
2.5 KCl, 1.25 NaH2PO4, 1.3 MgSO4, 2.4 CaCl2, 26 NaHCO3, and 10 
glucose. Presynaptic stimulation was applied to the medial 
perforant pathway of the dentate gyrus using a bipolar insulated 
tungsten wire electrode, and field excitatory postsynaptic 
potentials (EPSPs) were recorded at a control test frequency of 
0.033 Hz from the middle one-third of the molecular layer of the 
dentate gyrus with a glass microelectrode. LTP was induced with 
theta burst stimulation (TBS) consisting of nine bursts of four 
pulses at 100 Hz, 200 ms interburst interval, 5 min intertrain 
interval. All solutions contained 100 μM picrotoxin (Sigma) to 
block GABAA-mediated activity. 
All data are presented as mean ± SEM and “n” indicates the 
number of slices. Statistical significance was evaluated by unpaired 
Student's t test. Statistical significance was set at p < 0.05. 
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